Early day motion tabled by primary sponsor Liz Twist (Labour), on Monday, 24 November 2025, in the House of Commons. It is signed by 21 members in total.
Phenylketonuria awareness and access to treatment (No. 2)
That this House recognises the progress made in improving the care of people with phenylketonuria (PKU), a rare inherited metabolic disorder which prevents the body from properly metabolising phenylalanine; welcomes that many patients have benefitted from access to sapropterin, which has improved quality of life for some individuals living with PKU; notes, however, that significant unmet clinical needs remain, with many patients unable to benefit from existing treatments and still reliant on a highly restrictive diet; further recognises the continuing impact of PKU on patients, carers and families; and highlights the need for access to further innovative treatments and technologies that can improve outcomes and reduce the lifelong burden of PKU.
Secondary information
- Type
- Early day motion
- Reference
- 2358
- Session
- 2024-26
- Other sponsors
- Wera Hobhouse
- Jim Shannon
- Brian Mathew
- Ann Davies
- Vikki Slade
- Subjects
- Access Health education Medical treatments Phenylketonuria
- Link
- View this Early day motion on edm.parliament.uk
Librarians' tools
- Timestamp
- 2026-01-06 10:39:23 +0000
- URI
- http://data.parliament.uk/edms/64787
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/64787
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/64787